Non-Ischemic Congestive Heart Failure Treatment with Stem Cell Application

Non-Ischemic Congestive Heart Failure stem cell applicationNon-ischemic congestive heart failure, or non-ischemic cardiomyopathy, is heart failure that is unrelated to coronary artery disease and therefore has nothing to do with a poor coronary artery blood supply.

This type of heart failure means there is a weakness in the heart that has been caused by something other than coronary artery disease. There are four different types of non-ischemic congestive heart failure: Dilated cardiomyopathy, hypertrophic cardiomyopathy, restrictive cardiomyopathy and arrhythmogenic right ventricular dysplasia (ARVD).

Dilated cardiomyopathy (DCM) is the most prevalent form of non-ischemic cardiomyopathy. This condition means the heart has a decreased ability to pump blood around the body because the left ventricle, its main pumping chamber, has become dilated, weak or enlarged. The heart chambers rectify this by stretching to carry more blood through the body. At first this works as the blood is kept moving with a strengthened contraction.

However, over time the heart muscle walls begin to weaken and suffered reduced pumping strength. In many cases the kidneys react to this and retain extra sodium and fluid. When there is a build-up of fluid in areas like the legs, ankles, feet or lungs the body is congested, causing congestive heart failure.

Non-ischemic congestive heart failure symptoms include shortness of breath, swollen legs and feet, fatigue, weight gain, a congested cough, palpitations, dizziness, fainting and blood clots.

In most cases the cause of non-ischemic congestive heart failure is unknown.

New Stem Cell Application for Non-Ischemic Congestive Heart Failure


Adult stem cells are mutable and can morph into the cells of countless organs and structures within our bodies. Found in many therapies, they restore damaged tissues and rejuvenate aging cells through cell division, a process in which they multiply rapidly. Stem cell science has seen much advancement in recent years with many new discoveries being made.

Stem Cell Application in Mexico


Angeles Health’s Stem Cell Application program manages a variety of conditions including non-ischemic congestive heart failure. Like many other procedures treatment for non-ischemic congestive heart failure uses autologous adult stem cells. These are harnessed from the patient themselves so there is very little chance of a patient’s body rejecting them.
At Angeles hospital stem cells are taken from the patient’s bone marrow and adipose tissue, or fat. Adipose tissue extraction tends to be more fruitful than bone marrow extraction, due to the tissue producing up to ten times more stem cells, so it is much more widely used. It is also an easier process to carry out.

The therapeutic endovascular placement of adipose-derived stem cells that characterizes Stem Cell Application treatment at Hospital Angeles enables organs and structures to be targeted directly.
The specialized non-invasive catheterization process is not taxing on the patient. Stem cells can be distributed around the body, there is no need for an anesthetic and the therapy is over in less than an hour.

Angeles Health International is a Center of Excellence and offers patients the best therapies that are of the highest quality. We work with licensed medical professionals who adhere to formally appointed bodies of expertise. Angeles hospital prides itself on maintaining the highest standards of treatment and investigative research in stem cell application.

Contact Angeles Hospital!


To discover more about Stem Cell Application and the treatments available at Angeles hospital in Mexico please contact us using the form to your right.

Inclusion/exclusion criteria

Find out more